Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
5.16
-0.06 (-1.15%)
At close: Jan 2, 2026, 4:00 PM EST
5.19
+0.03 (0.57%)
Pre-market: Jan 5, 2026, 8:00 AM EST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $59.26 million as of January 5, 2026. Its market cap has increased by 65.61% in one year.
Market Cap
59.26M
Enterprise Value
38.50M
1-Year Change
65.61%
Ranking
Category
Stock Price
$5.16
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $59.26M, a decrease of -18.65%. That is a compound annual growth rate of -4.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 59.26M | 0.27% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |